Episode 10: How Biosimilars Could Impact the Future of Cancer Care
Rowena Schwartz, PharmD, BCOP, associate professor of pharmacy at the University of Cincinnati, joins Deborah Struth, MSN, RN, ONS research associate, to discuss the rapid emergence of biosimilar products on the market and how they’ll impact the treatment of cancer. Learn more about what biosimilars are, their approval processes, and the important things to know for practice.
Episode Notes:
- Biosimilars Offer New Options for Treatment and New Concepts for Patient Education
- Biosimilars: Considerations for Oncology Nurses
- S. Food and Drug Administration – Biosimilars
- American Society of Clinical Oncology Statement: Biosimilars in Oncology
- Chemotherapy, Biotherapy, and Hormonal Therapy Resources
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Listen on:
Listen on Amazon Music, Listen on Apple Podcasts, Listen on Google Podcasts, Listen on Spotify